By Ronda Fears
Nashville, Jan. 31 - Nuvelo, Inc. sold 6.5 million shares of common stock in a follow-on offering priced at $16.00 each versus Monday's close of $16.03 via joint bookrunners J.P. Morgan Securities Inc. and Deutsche Bank Securities Inc.
Lehman Brothers Inc. was co-manager.
San Carlos, Calif.-based Nuvelo said net proceeds, estimated at $97.3 million, will be used for general corporate purposes, including the advancement of drug candidates in clinical trials, the development of a commercialization infrastructure, capital expenditures and to meet working capital needs.
| Issuer: | Nuvelo, Inc.
|
| Issue: | Follow-on stock offering
|
| Gross proceeds: | $104 million
|
| Net proceeds: | $97.3 million
|
| Shares: | 6.5 million shares
|
| Greenshoe: | 975,000 shares
|
| Price: | $16.00 per share
|
| Bookrunners: | J.P. Morgan Securities Inc. and Deutsche Bank Securities Inc.
|
| Co-manager: | Lehman Brothers Inc.
|
| Pricing date: | Jan. 30
|
| Settlement date: | Feb. 3
|
| Stock symbol: | Nasdaq: NUVO
|
| Stock price: | $16.03 at close Jan. 30
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
